Jazz Pharmaceuticals plc buy The Goldman Sachs Group, Inc.
Start price
05.06.24
/
50%
€98.06
Target price
05.06.25
€155.23
Performance (%)
-1.35%
End price
06.06.25
€96.74
Summary
This prediction ended on 06.06.25 with a price of €96.74. With a performance of -1.35%, the BUY prediction by The_Goldman_Sachs_Gr finished with a loss. The_Goldman_Sachs_Gr has a follow-up prediction for Jazz Pharmaceuticals plc where he still thinks Jazz Pharmaceuticals plc is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Jazz Pharmaceuticals plc | 0.783% | 0.783% | 20.468% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $169.00 price target on the stock.
Ratings data for JAZZ provided by MarketBeat
In the thread Trading Jazz Pharmaceuticals plc
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by The_Goldman_Sachs_Gr for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€109.20
29.08.25
29.08.25
€158.67
29.08.26
29.08.26
29.62%
18.12.25
18.12.25
Stopped prediction by The_Goldman_Sachs_Gr for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€137.36
03.03.23
03.03.23
€199.47
03.03.24
03.03.24
-19.63%
04.03.24
04.03.24